Turn Therapeutics Inc.
NASDAQTurn Therapeutics heads into its May 14 earnings report with a quiet but telling signal: every insider trade on record points in the same direction. A cluster of buys from the Acting CFO and a director accumulated over 77,000 net shares across the late 2025 period, at prices ranging from $2.61 to $4.95. That accumulation happened in the months following the stock's worst…
TTRX short interest surges 21.7% in a week to 68,803 shares, with utilization jumping to 14%, as the biotech stock reports earnings May 14.
Snapshot as of 25 Jun 2026
Turn Therapeutics heads into its May 14 earnings report with a quiet but telling signal: every insider trade on record points in the same direction. A cluster of buys from the Acting CFO and a director accumulated over…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TTRX — free to start on ORTEX.
Sign up for free →Open TTRX on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live TTRX data →